Nexium Approved for Young Children

The FDA has approved esomeprazole magnesium (Nexium) for children ages 1 to 11 years to treat gastroesophageal reflux disease in the short term. The drug is approved as a delayed-release capsule and liquid form, in both 10-mg and 20-mg daily doses.

Side effects in pediatric patients include headache, diarrhea, abdominal pain, nausea, gas, constipation, dry mouth, and sleepiness.

The drug had previously been approved for use in adults and children ages 12 to 17 years.